Link Details

Prescription Drug Advertising and Health Reform

Research by Kantar Media tracks drug advertising by pharmaceutical companies “Big Pharma”. It’s big business at nearly $6.9 billion in 2021 ad spending direct-t0-consumers. At the top of 2021’s spending list was Dupixent (by Sanofi and Regeneron) for atopic dermatitis.  That was followed by Novo Nordisk’s Rybelsus (diabetes). Next in order: AbbVie’s anti-inflamatory drug Humira and Rinvoq, a rheumatoid arthritis drug. Fifth was Trulicity, made by Eli Lilly (diabetes). The size of ad spending to consumers raises questions about the disadvantages of the US continuing to allow direct-to-consumer advertising of prescription drugs. Published April 2022.  The spending level for 2021 equates to big pharma spending almost $19 Million every day to promote prescription drugs to consumers.




Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search

Consumer Health Ratings